Mettler-Toledo International, Inc. $MTD Stock Position Cut by Russell Investments Group Ltd.

Russell Investments Group Ltd. lessened its stake in shares of Mettler-Toledo International, Inc. (NYSE:MTD) by 7.6% during the second quarter, Holdings Channel.com reports. The fund owned 107,639 shares of the medical instruments supplier’s stock after selling 8,863 shares during the period. Russell Investments Group Ltd.’s holdings in Mettler-Toledo International were worth $126,552,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Vanguard Group Inc. lifted its stake in Mettler-Toledo International by 0.5% during the second quarter. Vanguard Group Inc. now owns 2,556,707 shares of the medical instruments supplier’s stock valued at $3,003,415,000 after purchasing an additional 13,342 shares during the last quarter. Bank of New York Mellon Corp raised its position in Mettler-Toledo International by 71.3% during the second quarter. Bank of New York Mellon Corp now owns 904,264 shares of the medical instruments supplier’s stock valued at $1,062,257,000 after buying an additional 376,419 shares during the period. Alliancebernstein L.P. lifted its position in shares of Mettler-Toledo International by 21.6% in the first quarter. Alliancebernstein L.P. now owns 709,328 shares of the medical instruments supplier’s stock worth $837,653,000 after purchasing an additional 126,147 shares in the last quarter. Geode Capital Management LLC boosted its stake in shares of Mettler-Toledo International by 0.6% during the 2nd quarter. Geode Capital Management LLC now owns 581,847 shares of the medical instruments supplier’s stock valued at $681,489,000 after buying an additional 3,383 shares during the period. Finally, Price T Rowe Associates Inc. MD grew its stake in Mettler-Toledo International by 5.5% in the first quarter. Price T Rowe Associates Inc. MD now owns 481,011 shares of the medical instruments supplier’s stock valued at $568,032,000 after purchasing an additional 25,272 shares in the last quarter. 95.07% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of equities research analysts recently issued reports on MTD shares. JPMorgan Chase & Co. upped their price objective on shares of Mettler-Toledo International from $1,200.00 to $1,285.00 and gave the stock a “neutral” rating in a report on Thursday, October 9th. Wells Fargo & Company boosted their price objective on shares of Mettler-Toledo International from $1,200.00 to $1,400.00 and gave the stock an “equal weight” rating in a report on Monday, November 10th. Robert W. Baird raised their target price on Mettler-Toledo International from $1,210.00 to $1,230.00 and gave the stock a “neutral” rating in a research report on Monday, August 4th. Evercore ISI lifted their price objective on Mettler-Toledo International from $1,275.00 to $1,400.00 and gave the company an “outperform” rating in a report on Tuesday, October 7th. Finally, Barclays upped their target price on shares of Mettler-Toledo International from $1,350.00 to $1,600.00 and gave the stock an “overweight” rating in a report on Monday, November 10th. Five investment analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company. Based on data from MarketBeat, Mettler-Toledo International has an average rating of “Hold” and an average target price of $1,406.50.

Insider Activity at Mettler-Toledo International

In related news, insider Gerry Keller sold 236 shares of the business’s stock in a transaction that occurred on Friday, November 21st. The stock was sold at an average price of $1,418.58, for a total value of $334,784.88. Following the completion of the transaction, the insider directly owned 159 shares in the company, valued at approximately $225,554.22. The trade was a 59.75% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Shawn Vadala sold 1,895 shares of the stock in a transaction on Tuesday, November 11th. The stock was sold at an average price of $1,455.52, for a total transaction of $2,758,210.40. Following the sale, the chief financial officer directly owned 5,288 shares of the company’s stock, valued at $7,696,789.76. This represents a 26.38% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders sold 19,565 shares of company stock valued at $28,683,737. 0.77% of the stock is owned by corporate insiders.

Mettler-Toledo International Trading Down 1.4%

Shares of NYSE MTD opened at $1,485.25 on Thursday. The firm’s 50-day moving average is $1,360.59 and its 200-day moving average is $1,269.64. Mettler-Toledo International, Inc. has a 1 year low of $946.69 and a 1 year high of $1,525.17. The firm has a market capitalization of $30.34 billion, a PE ratio of 37.61, a price-to-earnings-growth ratio of 4.19 and a beta of 1.41.

Mettler-Toledo International (NYSE:MTD) last posted its quarterly earnings results on Thursday, November 6th. The medical instruments supplier reported $11.15 earnings per share for the quarter, beating analysts’ consensus estimates of $10.62 by $0.53. The company had revenue of $1.03 billion for the quarter, compared to the consensus estimate of $997.36 million. Mettler-Toledo International had a negative return on equity of 476.07% and a net margin of 21.46%.The firm’s quarterly revenue was up 7.9% on a year-over-year basis. During the same quarter in the prior year, the business posted $10.21 EPS. Mettler-Toledo International has set its Q4 2025 guidance at 12.680-12.880 EPS. FY 2025 guidance at 42.050-42.250 EPS. As a group, equities research analysts anticipate that Mettler-Toledo International, Inc. will post 42.71 earnings per share for the current fiscal year.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.